Addex Therapeutics Ltd – Filings and Transcripts

NASDAQ: ADXN
Share price (11/6/26): $2.90
Market cap (11/6/26): $4.941 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

Late filing notification for annual report of foreign issuer

ended 12/31/24 FY 2024

Late filing notification for annual report of foreign issuer

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement

Updated info for already-effective prospectus

Prospectus supplement for primary offering

Ownership Filter

Teyssedou Lenaic Nathanael

Kalinichev Mikhail

Nunn Jason Raleigh

News Filter

Increases Issued Share Capital to Create Treasury Shares

Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia

Announces Executive Management Changes

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Regains Rights to GABAB Positive Allosteric Modulator Portfolio From Indivior

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness